Glycopyrronium, Formoterol

Bevespi Aerosphere

Sospensione pressurizzata per inalazioneItalyAuthorised

In other countries

The same active substances on other registers, the same brand first.

Bevespi AerosphereEuropean Union · AstraZeneca ABSame brand
Bevespi Aerosphere 7,2 Micrograme/5 MicrogrameRomania · 7,2 micrograme/5 micrograme · susp. de inhalat presurizata · Astrazeneca ABSame brand
Bevespi AerosphereUnited States · 0.0048MG/INH; 0.0090MG/INH · aerosol, metered · AstrazenecaSame brand
Glycopyrronium / Formoterol Fumarate Dihydrate Pressurized Inhalation SuspensionCanada · 5.8 MCG / ACT + 8.3 MCG / ACT · Aerosol (Metered-Dose) · Astrazeneca Canada INCSame substance

Packs

Pack	Code	Status
7,2 MCG / 5,0 MCG - SOSPENSIONE PRESSURIZZATA PER INALAZIONE - USO INALATORIO - INALATORE (ALLUMINIO/PLASTICA) - 1 INALATORE (120 EROGAZIONI)	047476015	Autorizzata
7.2 MCG / 5.0 MCG - SOSPENSIONE PRESSURIZZATA PER INALAZIONE - USO INALATORIO - INALATORE (ALLUMINIO/PLASTICA) - 3 (3 X 1) INALATORI (360 (3 X 120) EROGAZIONI) (CONFEZIONE MULTIPLA)	047476027

Two medicines in one question?

Name two or more medicines and Osler runs an interaction check. A severe interaction is stated at the very top of the answer.

Discover Osler

Glycopyrronium, Formoterol

Bevespi Aerosphere

Sospensione pressurizzata per inalazioneItalyAuthorised

Product informationAsk Osler about it

In other countries

The same active substances on other registers, the same brand first.

Packs

Pack	Code	Status
7,2 MCG / 5,0 MCG - SOSPENSIONE PRESSURIZZATA PER INALAZIONE - USO INALATORIO - INALATORE (ALLUMINIO/PLASTICA) - 1 INALATORE (120 EROGAZIONI)	047476015	Autorizzata
7.2 MCG / 5.0 MCG - SOSPENSIONE PRESSURIZZATA PER INALAZIONE - USO INALATORIO - INALATORE (ALLUMINIO/PLASTICA) - 3 (3 X 1) INALATORI (360 (3 X 120) EROGAZIONI) (CONFEZIONE MULTIPLA)	047476027

Two medicines in one question?

Name two or more medicines and Osler runs an interaction check. A severe interaction is stated at the very top of the answer.

Discover Osler

Documents

The official texts, at the regulator.

Sources and licences

Compiled by Prognia from the public register below; the register’s text is the official one.

Agenzia Italiana del Farmaco (AIFA), Italy

Agenzia Italiana del Farmaco (AIFA); https://drive.aifa.gov.it/farmaci/confezioni_fornitura.csv; HTTP Last-Modified Mon, 12 Oct 2026 23:02:44 GMT; acquired 2026-10-13T17:21:16.224007+00:00; native fields retained, source identifier and role projections are adaptations.

Licence: CC BY 4.0; AIFA published open-data catalog · Added 13 Oct 2026

Report an error or request removalCorrections from the holder or the register are welcome.

Prognia shows this product information for reference and learning. It is not treatment advice and can lag behind the official text. Always check the current product information and local protocols before prescribing.

At a glance

Active substances: Glycopyrronium, Formoterol
Dosage form: Sospensione pressurizzata per inalazione
Register: Italy (AIFA)
Status: Authorised
Status in the register: Autorizzata
Registration: AIC 047476
Marketing authorisation holder: Astrazeneca AB
ATC code: R03AL07
Group: Respiratory system
Procedure: Procedura Centralizzata
Supply: Medicinali soggetti a prescrizione medica